Does CRP predict outcome in bipolar disorder in regular outpatient care?

International Journal of Bipolar Disorders

Table 3 Number of subjects per medication type

Parameter	T0^a	T1^b	Total^c
Lithium (%)	31 (36.9)	47 (56)	48 (57.1)
Valproic acid (%)	14 (16.7)	9 (10.7)	16 (19.0)
Anti-inflammatory drugs (%)^d	12 (14.3)	12 (14.3)	16 (19.0)
Tricyclic antidepressants (TCA) (%)^d	5 (6)	5 (6)	7 (8.3)
Antidepressants (non-TCA) (%)	31 (36.9)	27 (32.1)	32 (38.1)
Antipsychotics (%)	35 (41.7)	34 (40.5)	39 (46.4)
Benzodiazepines (%)	31 (36.9)	31 (36.9)	39 (46.4)

^aMedication used up to and including the baseline (T0)
^bMedication used up to and including the time of episode change is such occurred (T1)
^cMedication used for the total period of the study (1 month before and up to 15 months after CRP measurement, unless episode change occurred earlier)
^dValues are the same for both T0 and T1 timepoints